References
- Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum Exp Toxicol 1997; 16:466–472.
- Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev 2003; 22:165–190.
- Eyer F, Meischner V, Kiderlen D, Thiermann H, Worek F, Haberkorn M, Felgenhauer N, Zilker T, Eyer P. Human parathion poisoning. A toxicokinetic analysis. Toxicol Rev 2003; 22:143–163.
- Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet 2008; 371:597–607.
- Willems JL, Belpaire FM. Anticholinesterase posioning: an overview of pharmacotherapy. In: Ballantyne BE, Marrs T, eds. Clinical and Experimental Toxicology of Organophosphates and Carbamates. Oxford: Butterworth-Heinemann Ltd; 1992:536–542.
- Casey PB, Blakey L, Bradberry SM, Vale JA. Late reactivation of erythrocyte cholinesterase activity by pralidoxime in a case of chlorpyrifos poisoning. Przeglad Lekarski 1995; 52:206.
- Eyer P. Optimal oxime dosage regimen, a pharmacokinetic approach. In: Szinicz L, Eyer P, Klimmek R, eds. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning. Heidelberg: Spektrum, Akademischer Verlag; 1996:33–51.
- Eyer F, Worek F, Eyer P, Felgenhauer N, Haberkorn M, Zilker T, Thiermann H. Obidoxime in acute organophosphate poisoning: 1 – clinical effectiveness. Clin Toxicol 2009; DOI: 10.1080/15563650903206828.
- Besser R, Gutmann L, Dillmann U, Weilemann LS, Hopf HC. End-plate dysfunction in acute organophosphate intoxication. Neurology 1989; 39:561–567.
- Thiermann H, Radtke M, Spöhrer U, Klimmek R, Eyer P. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7. Arch Toxicol 1996; 70:293–299.
- Grubic Z, Sketelj J, Klinar B, Brzin M. Recovery of acetylcholinesterase in the diaphragm, brain, and plasma of the rat after irreversible inhibition by soman: a study of cytochemical localization and molecular forms of the enzyme in the motor end plate. J Neurochem 1981; 37:909–916.
- Sidell FR, Groff WA, Kaminskis A. Toxogonin and pralidoxime: kinetic comparison after intravenous administration to man. J Pharm Sci 1972; 61:1765–1769.
- Taylor P, Radic Z. The cholinesterases: from genes to proteins. Annu Rev. Pharmacol Toxicol 1994; 34:281–320.
- Thiermann H, Eyer P, Worek F, Szinicz L. Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon. Toxicology 2005; 214:190–197.
- Alberts P. A new H-oxime restores rat diaphragm contractility after esterase inhibition in vitro. Eur J Pharmacol 1990; 184:191–194.
- Stenzel J, Worek F, Eyer P. Preparation and characterization of dialkylphosphoryl-obidoxime conjugates, potent anticholinesterase derivatives that are quickly hydrolyzed by human paraoxonase (PON1192Q). Biochem Pharmacol 2007; 74:1390–1400.
- Eyer P, Kiderlen D, Stenzel J, Thiermann H, Worek F. Paraoxonase polymorphism. A modifying factor that influences oxime effectiveness. Clin Toxicol 2006; 44:440–441.
- Worek F, Diepold C, Eyer P. Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch Toxicol 1999; 73:7–14.
- Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale A, Haines JA. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000; 12:22–37.
- Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von Meyer L, Juszczak E, Hittarage A, Azhar S, Dissanayake W, Sheriff MH, Szinicz L, Dawson AH, Buckley NA. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005; 366:1452–1459.
- Eddleston M, Eyer P, Worek F, Juszczak E, Adler N, Mohamed F, Senarathna L, Hittarage A, Azher S, Jeganathan K, Jayamanne S, von Meyer L, Dawson AH, Sheriff MH. Buckley NA. Pralidoxime in acute organophosphorus insecticide poisoning – a randomised controlled trial. PLoS Med 2009; 6:e1000104.